ADC Therapeutics S.A.(ADCT)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | Redmile Group, LLC 10% Owner | Sale | -5,880,415 | -20.41%22,932,028 | $3.34 | $19,636,340 | View SEC filing | |
| 2025-10-28 | Redmile Group, LLC 10% Owner | Purchase | +7,692,306 | +100.00%7,692,306 | $3.90 | $29,999,993 | View SEC filing | |
| 2025-06-13 | Redmile Group, LLC 10% Owner | Purchase | +28,199,501 | +100.00%28,199,501 | $3.43 | $96,780,687 | View SEC filing | |
| 2024-12-13 | Redmile Group, LLC 10% Owner | Purchase | +200,000 | +0.70%28,812,443 | $3.04 | $609,000 | View SEC filing | |
| 2024-12-06 | Redmile Group, LLC 10% Owner | Sale | -25,352 | -0.16%15,566,731 | $2.07 | $52,479 | View SEC filing | |
| 2024-07-03 | Redmile Group, LLC 10% Owner | Purchase | +800,000 | +2.87%28,664,257 | $2.81 | $2,248,000 | View SEC filing | |
| 2024-06-18 | Azelby Robert Director | Sale | -6,995 | -11.66%53,005 | $2.89 | $20,216 | View SEC filing | |
| 2024-06-18 | BIZZARI JEAN-PIERRE Director | Sale | -6,995 | -8.09%79,502 | $2.89 | $20,216 | View SEC filing | |
| 2024-06-18 | Hug Peter Director | Sale | -1,193 | -0.65%182,644 | $2.89 | $3,448 | View SEC filing | |
| 2024-06-18 | Monges Viviane Director | Sale | -1,437 | -1.33%106,627 | $2.89 | $4,153 | View SEC filing | |
| 2024-06-18 | Pfisterer Thomas Director | Sale | -1,437 | -0.22%665,756 | $2.89 | $4,153 | View SEC filing | |
| 2024-06-18 | Sandor Victor Director | Sale | -6,995 | -7.96%80,886 | $2.89 | $20,216 | View SEC filing | |
| 2024-06-18 | Squarer Ron Director | Sale | -6,995 | -7.98%80,663 | $2.89 | $20,216 | View SEC filing | |
| 2024-05-10 | Redmile Group, LLC 10% Owner | Purchase | +14,270,446 | +100.00%14,270,446 | $4.81 | $68,669,386 | View SEC filing | |
| 2024-05-09 | MALLIK AMEET Chief Executive Officer | Sale | -29,731 | -2.48%1,167,348 | $4.48 | $133,195 | View SEC filing |
1-15 of 15